-+ 0.00%
-+ 0.00%
-+ 0.00%

COGENT BIOSCIENCES ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR BEZUCLASTINIB IN PATIENTS WITH NONADVANCED SYSTEMIC MASTOCYTOSIS (NONADVSM)

Reuters·03/16/2026 12:00:10

Please log in to view news